Nicotinell Mint (Nicotine Polacrilex)

Nicotine Polacrilex, the active ingredient in Nicotinell Mint, is a nicotine replacement therapy presented as an oral formulation for buccal use. It is intended to help adults who are trying to quit smoking by delivering controlled nicotine to reduce withdrawal symptoms and cravings.\n\nGNH India supplies Nicotinell Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Mint is a nicotine replacement product used in the management of tobacco‑related dependence.\n\nSmoking cessation: assists adults in quitting cigarettes by providing a controlled nicotine dose.\nTobacco dependence: supports gradual reduction of nicotine intake in habitual smokers.\nNicotine withdrawal management: alleviates cravings and withdrawal symptoms during the quitting process.

Nicotinell Mint may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Mouth irritation or soreness\n- Hiccups\n- Nausea or upset stomach\n- Dyspepsia\n- Headache\n- Dizziness\n\nSerious or Rare Side Effects:\n- Allergic reaction (rash, swelling, itching)\n- Chest pain or palpitations\n- Arrhythmia\n- Severe mouth ulceration\n- Anaphylaxis\n- Severe skin rash or Stevens‑Johnson‑like reaction

When using Nicotinell Mint, consider the following safety measures.\n\nAssess nicotine dependence level: determine appropriate dosing under professional guidance.\nAvoid use after recent myocardial infarction or unstable angina.\nDo not combine with other nicotine‑containing products (e.g., cigarettes, patches).\nIncorporate into a comprehensive quit‑smoking plan with behavioral support.\nKeep out of reach of children and pets.\nStore at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotinell Mint can interact with other substances that affect nicotine metabolism or cardiovascular response.\n\nMajor Interactions (Avoid):\n- Concurrent use of other nicotine products: risk of nicotine overdose.\n- Use with monoamine oxidase inhibitors: may intensify cardiovascular effects.\n\nModerate Interactions (Monitor Closely):\n- Beta‑blockers: nicotine‑induced tachycardia may be masked.\n- CYP2A6 inhibitors (e.g., certain antifungals): may alter nicotine clearance.\n- Bupropion or varenicline: increased likelihood of side‑effects such as insomnia or nausea.